Neuroleptic malignant syndrome induced by quetiapine and fluvoxamine.
Matsumoto
Ryohei
R
Kitabayashi
Yurinosuke
Y
Nakatomi
Yasuhito
Y
Tsuchida
Hideto
H
Fukui
Kenji
K
D014150:Antipsychotic Agents / Q000009:adverse effects*; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D003987:Dibenzothiazepines / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D016666:Fluvoxamine / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000069348:Quetiapine Fumarate; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D016666:Fluvoxamine; D000069348:Quetiapine Fumarate; D017367:Selective Serotonin Reuptake Inhibitors